Welcome to our dedicated page for AirSculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on AirSculpt Technologies stock.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) is an innovative leader in the body contouring industry, delivering premium cosmetic procedures under its renowned brand, Elite Body Sculpture. Utilizing its patented AirSculpt® technology, the company offers minimally invasive procedures that remove unwanted fat, tighten skin, and sculpt targeted areas of the body. These procedures are designed for quick healing with minimal bruising, making them highly sought after among patients looking for effective and efficient results.
Established in 2012, AirSculpt has expanded its reach with over 27 state-of-the-art facilities across the United States, Canada, and the United Kingdom. Recent expansions include the redesign of its Scottsdale location and the relocation of its Atlanta office to cater to the growing demand for its services. The company has continually innovated, recently introducing the AirSculpt® Lift for facial rejuvenation and AirSculpt®+ for enhanced skin tightening, further solidifying its position in the market.
Financially, AirSculpt has shown robust growth, reporting a significant increase in both revenue and case volume. In the third quarter of 2023, the company saw a 20.3% rise in revenue, amounting to $46.8 million, and a 19% increase in case volume to 3,426 cases. Despite facing macroeconomic challenges, the company's strategic investments in new locations and customer acquisition have continued to drive its performance. AirSculpt's financial health is further strengthened by a positive cash flow and a solid balance sheet, with $11.0 million in cash and equivalents as of March 31, 2024.
A key aspect of AirSculpt's success is its commitment to providing an unmatched patient experience. The company's procedures are not only effective but also comfortable, with patients remaining awake during the process. Partnerships with influencers and celebrities, like Kristen Doute from Bravo's The Valley, have enhanced the company's visibility and credibility, attracting a broader audience.
Looking forward, AirSculpt remains dedicated to expanding its footprint with plans to open six new centers in 2024. The company's outlook projects continued revenue growth and increased adjusted EBITDA, demonstrating confidence in its ability to scale and meet the rising demand for body contouring services. AirSculpt Technologies uses its website as a primary channel for disseminating important company information and engages regularly with investors through conference calls and updates.
AirSculpt Technologies (NASDAQ:AIRS) has appointed Yogi Jashnani as Chief Executive Officer and Board member, effective January 7, 2025. Jashnani succeeds Interim CEO Dennis Dean, who will continue as Chief Financial Officer. With over two decades of experience, Jashnani joins from Sky Zone where he served as Chief Revenue Officer.
Previously, as Chief Commercial Officer at Ideal Image, Jashnani drove growth through loyalty programs and new services. His experience includes executive roles at Advance Auto Parts, where he doubled eCommerce revenue, and Capital One Financial Services. The appointment aims to capitalize on AirSculpt's market position in premium body contouring procedures.
Jashnani's priorities will focus on accelerating same-center sales growth, enhancing operational efficiencies, and maximizing the potential of the AirSculpt method.
AirSculpt Technologies (NASDAQ: AIRS) has announced the opening of its new body contouring center in White Plains, NY, marking its 32nd location. The new facility features three operating rooms for simultaneous procedures and offers the AirSculpt+ skin tightening procedure. This expansion represents the company's second location in New York, responding to growing market demand. The AirSculpt+ procedure combines fat removal with Renuvion® technology, using helium gas and radiofrequency energy for skin tightening. Since 2012, over 60,000 AirSculpt procedures have been performed across their locations in the U.S., Canada, and the United Kingdom.
AirSculpt Technologies (NASDAQ:AIRS) reported Q3 2024 results with revenue of $42.5 million, representing a 9.1% decline from Q3 2023. The company posted a net loss of $6.0 million and Adjusted EBITDA of $4.7 million. Case volume decreased 4.3% to 3,277 cases. Despite challenges in the consumer environment, the company opened four new centers during the quarter. For the first nine months of 2024, revenue declined 4.8% to $141.2 million. The company affirmed its 2024 guidance with revenue expected between $183-189 million and Adjusted EBITDA between $23-28 million.
AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring procedures, has opened a new center in Birmingham, MI, increasing its total locations to 31. The center, located at 555 S. Old Woodward Avenue Suite 500, features two operating rooms for concurrent procedures and offers the popular AirSculpt®+ skin tightening procedure.
Dennis Dean, Interim CEO, expressed excitement about introducing AirSculpt's exclusive technology to Birmingham. The clinic is situated on the main strip, surrounded by upscale retail shops. AirSculpt®+ combines AirSculpt® fat removal with Renuvion® treatment, using helium gas and radiofrequency energy to tighten skin and improve laxity.
Since 2012, over 60,000 AirSculpt® cases have been performed across the company's locations in the U.S., Canada, and the United Kingdom.
AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leading provider of premium body contouring procedures, has announced the opening of a new center in Deerfield, IL. This expansion brings the company's total location count to 30. The new center, located at 720 Waukegan Rd Suite 200, features three operating rooms and offers the popular AirSculpt®+ skin tightening procedure.
Dennis Dean, Interim CEO, expressed excitement about bringing AirSculpt's proprietary technology to Deerfield, citing strong demand in their existing Chicago clinic. The AirSculpt®+ procedure combines AirSculpt® fat removal with Renuvion® skin tightening technology, offering patients a comprehensive body contouring solution.
Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom. The company continues to expand its presence to meet growing market demand for premium body contouring services.
AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring, has opened its 29th center in Columbus, OH. The new facility, located at 4100 Regent St Suite 4-H in Easton Town Center, features two operating rooms for concurrent procedures. The center also offers the popular AirSculpt®+ skin tightening procedure, which combines AirSculpt® fat removal with Renuvion® technology for improved skin laxity. This minimally invasive treatment uses helium gas and radiofrequency energy to create a plasma that corrects sagging skin and restores a youthful appearance. Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom.
AirSculpt Technologies (NASDAQ:AIRS) reported Q2 2024 results with revenue of $51.0 million, a net loss of $3.2 million, and Adjusted EBITDA of $6.9 million. The company faced challenges due to a difficult consumer spending environment and increased brand awareness spend. Key points include:
- Case volume declined 5.7% to 3,949
- Revenue decreased 8.4% year-over-year
- Net loss of $3.2 million compared to $1.8 million net income in Q2 2023
- Adjusted EBITDA of $6.9 million, down from $14.6 million in Q2 2023
AirSculpt revised its 2024 guidance, projecting revenues of $180-$190 million and Adjusted EBITDA of $23-$28 million. The company plans to open five new centers in H2 2024. Dennis Dean has been appointed Interim CEO following Todd Magazine's resignation.
AirSculpt Technologies, Inc. (NASDAQ:AIRS), a national provider of premium body contouring procedures, has announced significant leadership changes. Todd Magazine has stepped down as Chief Executive Officer and Board member, transitioning to an advisory role until December 31, 2024. Dennis Dean, the company's Chief Financial Officer, has been appointed as interim CEO while a search for a permanent successor is conducted.
Dr. Aaron Rollins, Executive Chairman, expressed confidence in the company's business model and growth potential. The focus will be on core body contouring procedures, reducing long-term marketing spend, and increasing fiscal discipline in response to the current economic environment. Dennis Dean emphasized the company's plan to focus on core operations, reduce expenses, and position for efficient scaling to deliver consistent revenue growth with industry-leading EBITDA margins as conditions improve.
AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures, has announced its plans to report second quarter 2024 financial results. The company will release its earnings before the market opens on Friday, August 9, 2024, followed by a conference call at 8:30 a.m. Eastern Time on the same day.
Investors and interested parties can access the conference call by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871. Alternatively, they can request a return call for instant telephone access. A live webcast of the call will be available on the investor relations section of the AirSculpt Technologies website, with a replay accessible for approximately 90 days after the event.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 2.9% increase in first-quarter cases to 3,746 and a 3.9% revenue increase to $47.6 million. Net income rose to $6.0 million from a loss in the previous year. The company plans six new center openings in 2024 and maintains revenue guidance of $220 million.
FAQ
What is the current stock price of AirSculpt Technologies (AIRS)?
What is the market cap of AirSculpt Technologies (AIRS)?
What does AirSculpt Technologies, Inc. specialize in?
Where are AirSculpt's procedures available?
What recent innovations has AirSculpt introduced?
How has AirSculpt performed financially?
What are AirSculpt's future plans?
Who are some notable clients of AirSculpt?
How does AirSculpt ensure a premium patient experience?
What are the benefits of AirSculpt® technology?
How does AirSculpt keep investors informed?
What is AirSculpt's approach to growth and expansion?
